Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement

被引:20
|
作者
Goldman, Jennifer L. [1 ]
Chung, Wen-Hung [2 ]
Lee, Brian R. [3 ]
Chen, Chun-Bing [2 ]
Lu, Chun-Wei [2 ]
Hoetzenecker, Wolfram [4 ]
Micheletti, Robert [5 ]
Yasuda, Sally Usdin [6 ]
Margolis, David J. [5 ,7 ]
Shear, Neil H. [8 ,9 ]
Struewing, Jeffery P. [10 ]
Pirmohamed, Munir [11 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Pediat Infect Dis & Clin Pharmacol, Dept Pediat, 2401 Gillham Rd, Kansas City, MO 64108 USA
[2] Chang Gung Univ, Drug Hypersensit Clin & Res Ctr, Keelung & Linkou Branches, Chang Gung Mem Hosp,Dept Dermatol,Coll Med, Taipei, Taiwan
[3] Childrens Mercy Hosp Clin, Div Hlth Serv & Outcomes Res, Kansas City, MO USA
[4] Univ Hosp Linz, Dept Dermatol, Linz, Austria
[5] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[6] US FDA, Silver Spring, MD USA
[7] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[8] Sunnybrook Hlth Sci Ctr, Div Dermatol, Dept Med, Toronto, ON, Canada
[9] Univ Toronto, Toronto, ON, Canada
[10] NHGRI, Div Genom Med, NIH, Bethesda, MD USA
[11] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
关键词
Causality assessment tool; Adverse drug reactions; Stevens-Johnson syndrome; Toxic epidermal necrolysis; EXPERT JUDGMENT;
D O I
10.1007/s00228-019-02670-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PurposeEstablishment of causality between drug exposure and adverse drug reactions (ADR) is challenging even for serious ADRs such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Several causality assessment tools (CAT) exist, but the reliability and validity of such tools is variable. The objective of this study was to compare the reliability and validity of existing ADR CATs on SJS/TEN cases.MethodsSeven investigators completed three CAT (ALDEN, Naranjo, Liverpool) for 10 SJS/TEN cases. Each CAT categorized the causality of 30 potential drugs as definite/very probable, probable, possible, or doubtful/unlikely. An additional reviewer provided expert opinion by designating the implicated drug(s) for each case. A Kappa score was generated to compare CAT responses both by method (reliability of all 7 reviewers, by CATs) and by reviewer (reliability of the 3 CAT, by reviewer). A c statistic was calculated to assess validity.ResultsInter-rater reliability by CAT was poor to fair: ALDEN 0.22, Naranjo 0.11, and Liverpool 0.12. Reliability was highest when causality classification was definite/very probable (0.16-0.41). Similarly, intra-rater reliability by reviewer was poor. When comparing the validity of the overall CAT to expert reviewer, area under the curve was highest for ALDEN (c statistic 0.65) as compared to Liverpool (0.55) or Naranjo (0.54).ConclusionAvailable CAT have poor reliability and validity for drug-induced SJS/TEN. Due to the importance of determining ADR causality for research, industry, and regulatory purposes, development of an enhanced tool that can incorporate data from immunological testing and pharmacogenetic results may strengthen CAT usefulness and applicability for drug-induced SJS/TEN.
引用
收藏
页码:1135 / 1141
页数:7
相关论文
共 50 条
  • [41] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Lerch, Marianne
    Mainetti, Carlo
    Beretta-Piccoli, Benedetta Terziroli
    Harr, Thomas
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (01) : 147 - 176
  • [42] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Evaluation
    Dicle, Oezlem
    Yilmaz, Ertan
    Alpsoy, Erkan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (01): : 15 - 20
  • [43] Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Chronopoulos, A.
    Pleyer, U.
    Mockenhaupt, M.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 534 - 539
  • [44] Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
    Fagot, JP
    Mockenhaupt, M
    Bouwes-Bavinck, JN
    Naldi, L
    Viboud, C
    Roujeau, JC
    AIDS, 2001, 15 (14) : 1843 - 1848
  • [45] Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Jaller, Jose A.
    McLellan, Beth N.
    Balagula, Yevgeniy
    CURRENT DERMATOLOGY REPORTS, 2020, 9 (01) : 58 - 72
  • [46] Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Spectrum for the Rheumatologist
    Parida, Jyoti Ranjan
    Tripathy, Saumya Ranjan
    INDIAN JOURNAL OF RHEUMATOLOGY, 2019, 14 : S67 - S75
  • [47] Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    Marianne Lerch
    Carlo Mainetti
    Benedetta Terziroli Beretta-Piccoli
    Thomas Harr
    Clinical Reviews in Allergy & Immunology, 2018, 54 : 147 - 176
  • [48] Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
    Vivar, Karina L.
    Mancl, Kimberly
    Seminario-Vidal, Lucia
    CLINICAL CASE REPORTS, 2018, 6 (02): : 258 - 261
  • [49] Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis
    Sato, Satoshi
    Kanbe, Tomoka
    Tamaki, Zenshiro
    Furuichi, Mihoko
    Uejima, Yoji
    Suganuma, Eisuke
    Takano, Tadamasa
    Kawano, Yutaka
    PEDIATRICS INTERNATIONAL, 2018, 60 (08) : 697 - 702
  • [50] An update on Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Koh, Mark Jean-Aan
    Tay, Yong-Kwang
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (04) : 505 - 510